ABSTRACT
BACKGROUND: Digital technologies, such as wearable devices and smartphone applications (apps), can enable the decentralisation of clinical trials by measuring endpoints in people's chosen locations rather than in traditional clinical settings. Digital endpoints can allow high-frequency and sensitive measurements of health outcomes compared to visit-based endpoints which provide an episodic snapshot of a person's health. However, there are underexplored challenges in this emerging space that require interdisciplinary and cross-sector collaboration. A multi-stakeholder Knowledge Exchange event was organised to facilitate conversations across silos within this research ecosystem. METHODS: A survey was sent to an initial list of stakeholders to identify potential discussion topics. Additional stakeholders were identified through iterative discussions on perspectives that needed representation. Co-design meetings with attendees were held to discuss the scope, format and ethos of the event. The event itself featured a cross-disciplinary selection of talks, a panel discussion, small-group discussions facilitated via a rolling seating plan and audience participation via Slido. A transcript was generated from the day, which, together with the output from Slido, provided a record of the day's discussions. Finally, meetings were held following the event to identify the key challenges for digital endpoints which emerged and reflections and recommendations for dissemination. RESULTS: Several challenges for digital endpoints were identified in the following areas: patient adherence and acceptability; algorithms and software for devices; design, analysis and conduct of clinical trials with digital endpoints; the environmental impact of digital endpoints; and the need for ongoing ethical support. Learnings taken for next generation events include the need to include additional stakeholder perspectives, such as those of funders and regulators, and the need for additional resources and facilitation to allow patient and public contributors to engage meaningfully during the event. CONCLUSIONS: The event emphasised the importance of consortium building and highlighted the critical role that collaborative, multi-disciplinary, and cross-sector efforts play in driving innovation in research design and strategic partnership building moving forward. This necessitates enhanced recognition by funders to support multi-stakeholder projects with patient involvement, standardised terminology, and the utilisation of open-source software.
Subject(s)
Clinical Trials as Topic , Endpoint Determination , Stakeholder Participation , Humans , Clinical Trials as Topic/methods , Cooperative Behavior , Interdisciplinary Communication , Mobile Applications , Wearable Electronic Devices , Research Design , SmartphoneABSTRACT
INTRODUCTION: Pulmonary embolism (PE) is a well-recognised complication of COVID-19 infection, and chronic thromboembolic pulmonary disease with and without pulmonary hypertension (CTEPD/CTEPH) are potential life-limiting consequences. At present the burden of CTEPD/CTEPH is unclear and optimal and cost-effective screening strategies yet to be established. METHODS: We evaluated the CTEPD/CTEPH referral rate to the UK national multidisciplinary team (MDT) during the 2017-2022 period to establish the national incidence of CTEPD/CTEPH potentially attributable to COVID-19-associated PE with historical comparator years. All individual cases of suspected CTEPH were reviewed by the MDT for evidence of associated COVID-19. In a separate multicentre cohort, the risk of developing CTEPH following hospitalisation with COVID-19 was calculated using simple clinical parameters at a median of 5â months post hospital discharge according to existing risk scores using symptoms, ECG and NT pro-BNP. RESULTS: By the second year of the pandemic, CTEPH diagnoses had returned to the pre-pandemic baseline (23.1 versus 27.8 cases per month, p=0.252). Of 334 confirmed CTEPD/CTEPH cases, 4 (1.2%) patients were identified to have CTEPH potentially associated with COVID-19 PE, and a further 3 (0.9%) CTEPD without PH. Of 1094 patients (mean age 58â years, 60.4% male) hospitalised with COVID-19 screened across the UK, 11 (1.0%) were at high risk of CTEPH at follow-up, none of whom had a diagnosis of CTEPH made at the national MDT. CONCLUSION: A-priori risk of developing CTEPH following COVID-19-related hospitalisation is low. Simple risk scoring is a potentially effective way of screening patients for further investigation.
ABSTRACT
DNA double-strand breaks (DSBs), such as those produced by radiation and radiomimetics, are amongst the most toxic forms of cellular damage, in part because they involve extensive oxidative modifications at the break termini. Prior to completion of DSB repair, the chemically modified termini must be removed. Various DNA processing enzymes have been implicated in the processing of these dirty ends, but molecular knowledge of this process is limited. Here, we demonstrate a role for the metallo-ß-lactamase fold 5'-3' exonuclease SNM1A in this vital process. Cells disrupted for SNM1A manifest increased sensitivity to radiation and radiomimetic agents and show defects in DSB damage repair. SNM1A is recruited and is retained at the sites of DSB damage via the concerted action of its three highly conserved PBZ, PIP box and UBZ interaction domains, which mediate interactions with poly-ADP-ribose chains, PCNA and the ubiquitinated form of PCNA, respectively. SNM1A can resect DNA containing oxidative lesions induced by radiation damage at break termini. The combined results reveal a crucial role for SNM1A to digest chemically modified DNA during the repair of DSBs and imply that the catalytic domain of SNM1A is an attractive target for potentiation of radiotherapy.
Subject(s)
DNA Breaks, Double-Stranded , DNA Repair Enzymes , DNA Repair , Exodeoxyribonucleases , Humans , DNA Breaks, Double-Stranded/radiation effects , Exodeoxyribonucleases/metabolism , Exodeoxyribonucleases/genetics , DNA Repair Enzymes/metabolism , DNA Repair Enzymes/genetics , Proliferating Cell Nuclear Antigen/metabolism , Proliferating Cell Nuclear Antigen/genetics , DNA/metabolism , DNA/genetics , Ubiquitination , Cell Cycle ProteinsABSTRACT
The three human SNM1 metallo-ß-lactamase fold nucleases (SNM1A-C) play key roles in DNA damage repair and in maintaining telomere integrity. Genetic studies indicate that they are attractive targets for cancer treatment and to potentiate chemo- and radiation-therapy. A high-throughput screen for SNM1A inhibitors identified diverse pharmacophores, some of which were shown by crystallography to coordinate to the di-metal ion centre at the SNM1A active site. Structure and turnover assay-guided optimization enabled the identification of potent quinazoline-hydroxamic acid containing inhibitors, which bind in a manner where the hydroxamic acid displaces the hydrolytic water and the quinazoline ring occupies a substrate nucleobase binding site. Cellular assays reveal that SNM1A inhibitors cause sensitisation to, and defects in the resolution of, cisplatin-induced DNA damage, validating the tractability of MBL fold nucleases as cancer drug targets.
ABSTRACT
BACKGROUND: The NIHR's Associate Principal Investigator (API) Scheme in the United Kingdom was expanded nationally in 2020 with the aim of training clinicians to become Principal Investigators for clinical research in the future. The HEAL-COVID adaptive platform trial is an urgent public health study registered with the API Scheme. Within eighteen months of opening, the trial had recruited almost 1200 patients with over 100 active sites. Here we describe our experiences of APIs working on the trial with two broad objectives. Firstly, we aim to explore through qualitative methods the impact that the scheme has had on the APIs' professional development. Secondly, we aim to quantify the impact that the APIs have had on the recruitment of patients into the trial. METHODS: The professional backgrounds of the APIs are described from data from their application forms to the scheme. The HEAL-COVID API Network is described from records of the monthly meetings. The APIs' experiences are reviewed from data from the NIHR exit surveys at 6 months and from a reflective practice exercise at the final network meeting. Data of patient recruitment to HEAL-COVID was analysed for centres with and without APIs via a multivariate analysis. RESULTS: Forty-two APIs were registered with the HEAL-COVID trial with a diversity of backgrounds in terms of gender, country, profession, grade and specialty. Eleven monthly network meetings took place with the dual objectives of facilitating trial activity and providing educational content. Fourteen APIs completed the NIHR survey with all reporting Good Clinical Practice completion, local promotional activity of the trial, patient recruitment and support from their respective PI. Sites with at least one API recruited over 3.5 times more patients than sites without an API (medians 4 vs 14.5, p < 0.05), independent of factors including type of hospital or number of inpatient beds. DISCUSSION: This study adds to the growing literature that the NIHR's API Scheme is effective in meeting its objectives in providing research training to clinicians, thus building a workforce of future clinical researchers. Moreover, data from the HEAL-COVID trial shows that sites with an API are associated with higher recruitment. Overall, registering a trial with the API Scheme not only trains future clinical researchers, but it is also likely to increase the number of patients recruited (amongst other benefits), increasing the efficiency of trials and improving access for patients.
Subject(s)
COVID-19 , Humans , United KingdomSubject(s)
Cardiorespiratory Fitness , Exercise Test , Humans , Walk Test , Walking , Patient-Centered CareABSTRACT
Work engagement is a state of being happily engrossed in work and a feeling that one can give more in spite of difficulties, trials and tribulations. In line with this clergy engagement can be seen as a state in which priests constantly expend a great deal of energy through service and compassion to others with enthusiasm, commitment and absorption. The dynamic, dedicated and up-to-date priest thrives in demanding situations. Since engagement is defined as a work related state of mind 43 most of the studies have concentrated on the situational factors. This study attempts to explore if personality traits could play an important role in priests being positively motivated and engaged in priestly life and ministry. The present study on clergy engagement among a sample of 511 priests employed the Utrecht Work Engagement Scale to tap engagement, Copenhagen Psychosocial Questionnaire to tap ministerial resources and the NEO FFI Personality Inventory to tap personality traits, which is yet another addition to a long history of empirical research based on Catholic clergy conducted in various parts of the world. Hierarchical regression analyses confirmed that ministerial resources (skill utilization, social support from people and social support from priests) have a positive association with engagement and among the personality traits as expected Neuroticism had a negative association, while extraversion and conscientiousness had a positive association with engagement among the Indian clergy.
El engagement laboral es el estado de sentirse feliz y compenetrado hacia el trabajo, además de tener la capacidad de realizar un esfuerzo extra a pesar de las dificultades, procesos y preocupaciones. De forma paralela, el engagement del clero podría apreciarse como un estado en el cual los sacerdotes gastan comúnmente una gran cantidad de energía a través de su servicio y compasión hacia terceros con entusiasmo, compromiso y absorción. Los sacerdotes dinámicos, dedicados y modernos se enfrentan a situaciones exigentes. Debido a que el engagement se define como un estado mental hacia el trabajo, la mayoría de los estudios se han concentrado en los factores situacionales. Este estudio intenta explorar si los rasgos de la personalidad podrían jugar un rol importante en la motivación positiva y del engage en la vida sacerdotal y ministerial. El presente trabajo se realizó a partir de una muestra de 511 sacerdotes utilizando la medición Utrecht Work Engagement Scale para estimar el engagement, el Copenhagen Psychosocial Questionnaire para evaluar los recursos ministeriales y el NEO FFI Personality Inventory para revisar los rasgos de la personalidad, el cual es otra adición a una larga historia de investigación empírica basada en el clero católico que se realiza alrededor del mundo.Los análisis de regresión jerárquica confirmaron que los recursos ministeriales (uso de habilidades, apoyo social de la gente y apoyo social por parte de los sacerdotes) tienen una asociación positiva con el engagement y los rasgos de la personalidad. Tal como se esperaba, el neuroticismo presenta una asociación negativa, mientras que la extraversión y la conciencia mostraron una asociación positiva hacia el engagement del clero indio.